CN Patent

CN121909019A — 药物组合物

Assigned to Viiv Healthcare Uk Third Ltd · Expires 2026-04-21 · 0y expired

What this patent protects

本发明涉及人免疫缺陷病毒(HIV)预防和治疗。具体地，本发明涉及药物组合物，其包含：卡博特韦；润湿剂；稳定剂；以及张力调节剂；其中卡博特韦以质量中值直径(X50)在2.5 µm至10 µm之间(并且包括2.5 µm和10 µm)的颗粒形式存在。

USPTO Abstract

本发明涉及人免疫缺陷病毒(HIV)预防和治疗。具体地，本发明涉及药物组合物，其包含：卡博特韦；润湿剂；稳定剂；以及张力调节剂；其中卡博特韦以质量中值直径(X50)在2.5 µm至10 µm之间(并且包括2.5 µm和10 µm)的颗粒形式存在。

Drugs covered by this patent

Patent Metadata

Patent number
CN121909019A
Jurisdiction
CN
Classification
—
Expires
2026-04-21
Drug substance claim
No
Drug product claim
No
Assignee
Viiv Healthcare Uk Third Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.